Marybeth Carberry Joins Luventix as Advisor
Luventix, a leading innovator in Intelligent Disease Diagnostics, is pleased to announce that Marybeth Carberry has joined the organization as an Advisor.
Marybeth brings a wealth of experience in business operations leadership, with a strong track record of driving internal sales and business operations to maximize efficiency while ensuring customer satisfaction. With extensive experience leading cross-functional organizations through large-scale transformational change, she excels at driving change, leading global teams, and executing strategic company initiatives. Marybeth's background spans various functions, including Sales Operations, Customer Service, FP&A, and Human Resources.
"We are thrilled to welcome Marybeth Carberry to our team at Luventix," said George Holmes, CEO of Luventix. "Her vast experience in business operations and her ability to lead cross-functional teams through transformational change will be invaluable as we continue to scale our operations
About Luventix:
Luventix is a medical diagnostics company utilizing a simple, non-invasive urine test to detect and diagnose diseases through metabolomics modeling. By leveraging proprietary advanced machine learning (ML) modeling techniques, Luventix has the unique ability to analyze data and pinpoint disease-specific signatures within a Digital Twin, bridging the gap between diagnostics and therapeutics, revolutionizing clinical trial recruitment, and enabling companion diagnostics as an integral endpoint.
With a commitment to innovation, collaboration, and excellence, Luventix is redefining industry standards and making a meaningful impact on healthcare outcomes. By combining cutting-edge technology with strategic partnerships, Luventix aims to transform the landscape of personalized medicine and accelerate the delivery of life-changing solutions. For more information, please visit www.luventix.com.
Media Contact:
